We previously established TMEPAI-knockout (KO) cells from human triple-negative breast cancer (TNBC) cell lines and found that TMEPAI-KO cells showed reduced tumorigenic abilities. The gene discussed is PMEPA1; the disease is triple-negative breast carcinoma.